Intravitreal Bevacizumab in Myopic Neovascular Membranes: 24-Month Results
Intravitreal antiangiogenic drugs have been used recently to treat subfoveal myopic choroidal neovascularization (CNV) with good results. Several papers have reported on the outcome of intravitreal bevacizumab (IVB) in the short term, but very few have reported the long-term results compared with photodynamic therapy (PDT).